Nielsen Christian Lind, Dybdal Daniel Thor Halberg, Vester-Glowinski Peter, Hjalgrim Lisa Lyngsie, Wendtland Pernille Edslev, Kiil Birgitte Jul, Bendtsen Michael Melchior, Petersen Michael Mørk, Baad-Hansen Thomas
Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark.
Department of Paediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Acta Orthop. 2025 Jan 13;96:87-93. doi: 10.2340/17453674.2025.42848.
Vascularized fibular grafting following tumor resection is an essential treatment option in limb salvage surgery. We aimed to evaluate: (I) bone healing, (II) complications and reoperations, (III) limb salvage, and (IV) survival.
We present a retrospective evaluation of a national cohort comprising 27 patients. The indications were 13 cases of Ewing sarcoma, 12 cases of osteosarcoma, and 2 cases of giant cell tumor. The median age at surgery was 16 years (interquartile range [IQR] 10-18), and the median follow-up was 82 months (IQR 32-101). Patients were analyzed overall, as well as in subgroups based on tumor location (upper versus lower extremity) and pathology (osteosarcoma versus Ewing sarcoma).
The primary rate of graft union was 63%, and after secondary procedures the overall rate of graft union was 67%, with a median time to union of 13 months (IQR 9-17). The reoperation rate was 74%, while the limb salvage rate was 93%. The 5-year overall survival rate was 81% (95% confidence interval [CI] 61-92). Patients with upper extremity tumors were more likely to attain graft union (risk ratio [RR] 5.5, CI 1.3-31.5) and less likely to undergo multiple reoperations (RR 0.3, CI 0.8-0.9) than patients with lower extremity tumors.
Vascularized fibular grafting following tumor resection was associated with a graft union rate of 67%, a high frequency of reoperations, a high limb salvage rate (93%), and a 5-year survival rate of 81%.
肿瘤切除术后带血管蒂腓骨移植是保肢手术中的一种重要治疗选择。我们旨在评估:(I)骨愈合情况,(II)并发症及再次手术情况,(III)保肢情况,以及(IV)生存率。
我们对一个包含27例患者的全国性队列进行了回顾性评估。适应证包括13例尤因肉瘤、12例骨肉瘤和2例骨巨细胞瘤。手术时的中位年龄为16岁(四分位间距[IQR]10 - 18),中位随访时间为82个月(IQR 32 - 101)。对患者进行整体分析,并根据肿瘤位置(上肢与下肢)和病理类型(骨肉瘤与尤因肉瘤)分为亚组进行分析。
移植骨的初次愈合率为63%,二次手术后移植骨的总体愈合率为67%,愈合的中位时间为13个月(IQR 9 - 17)。再次手术率为74%,保肢率为93%。5年总生存率为81%(95%置信区间[CI]61 - 92)。与下肢肿瘤患者相比,上肢肿瘤患者更有可能实现移植骨愈合(风险比[RR]5.5,CI 1.3 - 31.5),且接受多次再次手术的可能性更小(RR 0.3,CI 0.8 - 0.9)。
肿瘤切除术后带血管蒂腓骨移植与67%的移植骨愈合率、较高的再次手术频率、较高的保肢率(93%)以及81%的5年生存率相关。